Implementing an Effective Diabetes Intervention Among Low-Income Immigrants - Trial NCT06319703
Access comprehensive clinical trial information for NCT06319703 through Pure Global AI's free database. This phase not specified trial is sponsored by NYU Langone Health and is currently Not yet recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 270 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Diabetes Self-Management Education and Support (DSMES) Videos
Interventional
behavioral
Sponsor & Location
NYU Langone Health
Timeline & Enrollment
N/A
May 01, 2024
Mar 31, 2028
Primary Outcome
Change in Hemoglobin A1C (HbA1c) Test Scores,Change in Hemoglobin A1C (HbA1c) Test Scores
Summary
The goal of this IDEAL project is to examine the effectiveness and implementation process of
 the video-based Diabetes Self-Management Education and Support (DSMES) + community health
 worker (CHW) (hereafter: IDEAL) intervention compared with a wait-list control group
 (hereafter: CONTROL) to improve glycemic control among Chinese immigrants with Type 2
 diabetes (T2D) in New York City (NYC). Participants will be randomized with equal allocation
 to one of the 2 groups. The IDEAL group will receive 1 DSMES brief video/week for 24 weeks
 delivered via text message. The CHW will assess participants' SDOH barriers to T2D care and
 link them to available resources in the community. The CONTROL group will continue to receive
 their usual care and at the end of the study, they will receive DSMES videos.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06319703
Non-Device Trial